101
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
102
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and 6147=1114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
103
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and make_set(6893=2866,2866)-- gyqp] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
104
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 having 9841=9307-- gcdk] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
105
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
106
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
107
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
108
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and 7716=(select (case when (7716=7716) then 7716 else (select 6720 union select 6499) end))-- mpzb] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
109
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and make_set(2234=2234,4853)] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/29/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
110
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
111
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 or extractvalue(8968,concat(0x5c,0x717a717671,(select (elt(8968=8968,1))),0x71706a6271))] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
112
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
113
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
114
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
115
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
116
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 or not 8501=8501#] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
117
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
118
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 or updatexml(4295,concat(0x2e,0x717a717671,(select (elt(4295=4295,1))),0x71706a6271),3985)] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
119
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and 2019=2019-- raye] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
120
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 having 2942=5474# auvi] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
121
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 rlike (select (case when (3342=4584) then 0x31302e313131312f7068702e3132383634 else 0x28 end))# okua] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
122
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
123
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
124
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
125
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 having 6037=6037# jzlz] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
126
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
127
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
128
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and updatexml(3081,concat(0x2e,0x717a717671,(select (elt(3081=3081,1))),0x71706a6271),1398)-- yyrn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
129
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and make_set(2234=2234,4853)# wsnb] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
130
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 or extractvalue(8968,concat(0x5c,0x717a717671,(select (elt(8968=8968,1))),0x71706a6271))# wgfn] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
131
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 or not 3194=3194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
132
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2018. [DOI: 10.1111/php.12864 and 1705=('qzqvq'||(select case 1705 when 1705 then 1 else 0 end from rdb$database)||'qpjbq')] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
133
|
Affiliation(s)
- Michael R. Hamblin
- Wellman Center for Photomedicine Massachusetts General Hospital Boston MA
- Department of Dermatology Harvard Medical School Boston MA
- Harvard‐MIT Division of Health Sciences and Technology Cambridge MA
| |
Collapse
|
134
|
Preoperative low level laser therapy in dogs undergoing tibial plateau levelling osteotomy: A blinded, prospective, randomized clinical trial. Vet Comp Orthop Traumatol 2017; 30:46-53. [DOI: 10.3415/vcot-15-12-0198] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2015] [Accepted: 10/19/2016] [Indexed: 01/19/2023]
Abstract
SummaryObjective: To evaluate the influence of pre-operative low-level laser therapy (LLLT) on therapeutic outcomes of dogs undergoing tibial plateau levelling osteotomy (TPLO).Methods: Healthy dogs undergoing TPLO were randomly assigned to receive either a single preoperative LLLT treatment (800–900 nm dual wavelength, 6 W, 3.5 J/cm2, 100 cm2 area) or a sham treatment. Lameness assessment and response to manipulation, as well as force plate analysis, were performed pre-operatively, then again at 24 hours, two weeks, and eight weeks postoperatively. Radiographic signs of healing of the osteotomy were assessed at eight weeks postoperatively.Results: Twenty-seven dogs (27 stifles) were included and no major complications occurred. At eight weeks postoperatively, a significant difference in peak vertical force analysis was noted between the LLLT (39.6% ± 4.7%) and sham groups (28.9% ± 2.6%), (p <0.01 Time, p <0.01 L). There were no significant differences noted between groups for all other parameters. The age of dogs in the LLLT group (6.6 ± 1.6 years) was greater than that for the sham group (4.5 ± 2.0, p <0.01). Although not significant, a greater proportion of LLLT dogs (5/8) had healed at the eight-week time point than in the sham group (3/12) despite the age difference (p = 0.11)Clinical significance: The results of this study demonstrate that improved peak vertical force could be related to the preoperative use of LLLT for dogs undergoing TPLO at eight weeks postoperatively. The use of LLLT may improve postoperative return to function following ca-nine osteotomies and its use is recommended.Supplementary Material to this article is available online at https://doi.org/10.3415/VCOT-15-12-0198.
Collapse
|
135
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864));select (case when (2286=2286) then 2286 else 1/(select 0) end)--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
136
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864");select dbms_pipe.receive_message(chr(107)||chr(117)||chr(76)||chr(121),32) from dual--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
137
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864;select count(*) from generate_series(1,32000000)--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
138
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864)));waitfor delay '0:0:32'--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
139
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864));select like('abcdefg',upper(hex(randomblob(3200000000/2))))--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
140
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864);(select * from (select(sleep(32)))xznt)#] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
141
|
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
142
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864);select dbms_pipe.receive_message(chr(107)||chr(117)||chr(76)||chr(121),32) from dual--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
143
|
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
144
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864";select sleep(32)#] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
145
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864";select (case when (6957=4400) then 6957 else 1/(select 0) end)--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
146
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864");select count(*) from generate_series(1,32000000)--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
147
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864");select like('abcdefg',upper(hex(randomblob(3200000000/2))))--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
148
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864"));select like('abcdefg',upper(hex(randomblob(3200000000/2))))--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
149
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864"));waitfor delay '0:0:32'--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|
150
|
Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol 2017. [PMID: 29164625 DOI: 10.1111/php.12864);waitfor delay '0:0:32'--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Photobiomodulation (PBM) involves the use of red or near-infrared light at low power densities to produce a beneficial effect on cells or tissues. PBM therapy is used to reduce pain, inflammation, edema, and to regenerate damaged tissues such as wounds, bones, and tendons. The primary site of light absorption in mammalian cells has been identified as the mitochondria and, more specifically, cytochrome c oxidase (CCO). It is hypothesized that inhibitory nitric oxide can be dissociated from CCO, thus restoring electron transport and increasing mitochondrial membrane potential. Another mechanism involves activation of light or heat-gated ion channels. This review will cover the redox signaling that occurs in PBM and examine the difference between healthy and stressed cells, where PBM can have apparently opposite effects. PBM has a marked effect on stem cells, and this is proposed to operate via mitochondrial redox signaling. PBM can act as a preconditioning regimen and can interact with exercise on muscles.
Collapse
Affiliation(s)
- Michael R Hamblin
- Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA.,Department of Dermatology, Harvard Medical School, Boston, MA.,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA
| |
Collapse
|